Comparison of Early Clinical Outcomes Following Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement versus Optimal Medical Therapy in Patients Older than 80 Years with Symptomatic Severe Aortic Stenosis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Transcatheter aortic valve implantation (TAVI) has become an attractive therapeutic strategy for severe aortic stenosis (AS) in elderly patients due to its minimally-invasive nature. Therefore, early results of its clinical outcomes in elderly Korean patients were evaluated. Materials and Methods: We compared early clinical outcomes of TAVI, surgical aortic valve replacement (SAVR), and optimal medical therapy (OMT) in patients aged ≥80 years with symptomatic severe AS. Treatment groups were allocated as follows: TAVI (n=10), SAVR (n=14), and OMT (n=42). Results: Baseline clinical characteristics including predicted operative mortality were similar among the three groups. However, patients with New York Heart Association functional class III or IV symptoms and smaller aortic valve area were treated with TAVI or SAVR rather than OMT. In-hospital combined safety endpoints (all-cause mortality, major stroke, peri-procedural myocardial infarction, life-threatening bleeding, major vascular complication, and acute kidney injury) after TAVI or SAVR were significantly lower in the TAVI group than in the SAVR group (10.0% vs. 71.4%, respectively, p=0.005), along with an acceptable rate of symptom improvement and device success. During the follow-up period, the TAVI group showed the lowest rate of 3-month major adverse cardiovascular and cerebrovascular events, a composite of all-cause mortality, myocardial infarction, major stroke, and re-hospitalization (TAVI 0.0% vs. SAVR 50.0% vs. OMT 42.9%, p=0.017). Conclusion: Treatment with TAVI was associated with lower event rates compared to SAVR or OMT. Therefore, TAVI may be considered as the first therapeutic strategy in selected patients aged ≥80 years with symptomatic severe AS.
Abstract
Purpose: Transcatheter aortic valve implantation (TAVI) has become an attractive therapeutic strategy for severe aortic stenosis (AS) in elderly patients due to its minimally-invasive nature. Therefore, early results of its clinical outcomes in elderly Korean patients were evaluated. Materials and Methods: We compared early clinical outcomes of TAVI, surgical aortic valve replacement (SAVR), and optimal medical therapy (OMT) in patients aged ≥80 years with symptomatic severe AS. Treatment groups were allocated as follows: TAVI (n=10), SAVR (n=14), and OMT (n=42). Results: Baseline clinical characteristics including predicted operative mortality were similar among the three groups. However, patients with New York Heart Association functional class III or IV symptoms and smaller aortic valve area were treated with TAVI or SAVR rather than OMT. In-hospital combined safety endpoints (all-cause mortality, major stroke, peri-procedural myocardial infarction, life-threatening bleeding, major vascular complication, and acute kidney injury) after TAVI or SAVR were significantly lower in the TAVI group than in the SAVR group (10.0% vs. 71.4%, respectively, p=0.005), along with an acceptable rate of symptom improvement and device success. During the follow-up period, the TAVI group showed the lowest rate of 3-month major adverse cardiovascular and cerebrovascular events, a composite of all-cause mortality, myocardial infarction, major stroke, and re-hospitalization (TAVI 0.0% vs. SAVR 50.0% vs. OMT 42.9%, p=0.017). Conclusion: Treatment with TAVI was associated with lower event rates compared to SAVR or OMT. Therefore, TAVI may be considered as the first therapeutic strategy in selected patients aged ≥80 years with symptomatic severe AS.
참고문헌 (36)
- Bonow RO, "2008 Focused update incorporated into the ACC", AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology, Circulation, pp.2008, 118[DOI]
- Varadarajan P, "Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis", Ann Thorac Surg, 82, pp.2111~2115 (2006)
- Iung B, "Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?", Eur Heart J, 26, pp.2714~2720 (2005)
- Chizner MA, "The natural history of aortic stenosis in adults", Am Heart J, 99, pp.419~424 (1980)
- O’Brien SM, "The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery", Ann Thorac Surg, 88(1), pp.S23~S42 (2009)
- Shahian DM, "The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery", Ann Thorac Surg, 88(1), pp.S43~S62 (2009)
- Lund O, "Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention", Circulation, 82, pp.124~139 (1990)
- Bose AK, "Aortic valve replacement in octogenarians", J Cardiothorac Surg, 2, pp.33~ (2007)
- Kolh P, "Aortic valve surgery in octogenarians: predictive factors for operative and long-term results", Eur J Cardiothorac Surg, 31, pp.600~606 (2007)
- Leontyev S, "Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE", Ann Thorac Surg, 87, pp.1440~1445 (2009)
- Faxon DP, "Transcatheter aortic valve implantation: coming of age", Circulation, 124, pp.e439~e440 (2011)
- Leon MB, "Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery", N Engl J Med, 363, pp.1597~1607 (2010)
- Smith CR, "Transcatheter versus surgical aortic-valve replacement in high-risk patients", N Engl J Med, 364, pp.2187~2198 (2011)
- Ewe SH, "Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis", Am Heart J, 160, pp.1113~1120 (2010)
- Gotzmann M, "One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis", Am J Cardiol, 107, pp.1687~1692 (2011)
- Eltchaninoff H, "Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry", Eur Heart J, 32, pp.191~197 (2011)
- Zahn R, "Transcatheter aortic valve implantation: first results from a multi-centre real-world registry", Eur Heart J, 32, pp.198~204 (2011)
- Rodés-Cabau J, "Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience", J Am Coll Cardiol, 55, pp.1080~1090 (2010)
- Buellesfeld L, "2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis", J Am Coll Cardiol, 57, pp.1650~1657 (2011)
- Moat NE, "Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry", J Am Coll Cardiol, 58, pp.2130~2138 (2011)
- Lang RM, "Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology", J Am Soc Echocardiogr, 18, pp.1440~1463 (2005)
- Otto CM, "Valvular aortic stenosis: disease severity and timing of intervention", J Am Coll Cardiol, 47, pp.2141~2151 (2006)
- Leon MB, "Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium", J Am Coll Cardiol, 57, pp.253~269 (2011)
- The GUSTO investigators, "An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction", N Engl J Med, 329, pp.673~682 (1993)
- 이삭, "Surgical Management of Coexisting Coronary Artery and Valvular Heart Disease", Yonsei Medical Journal, 51(3), pp.326~331 (2010), 연세대학교의과대학
- Bouma BJ, "To operate or not on elderly patients with aortic stenosis: the decision and its consequences", Heart, 82, pp.143~148 (1999)
- Lange R, "Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future", J Am Coll Cardiol, 59, pp.280~287 (2012)
- Tamburino C, "Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis", Circulation, 123, pp.299~308 (2011)
- Van Mieghem NM, "Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience", EuroIntervention, 5, pp.673~679 (2010)
- Tchetche D, "Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population", EuroIntervention, 5, pp.659~665 (2010)
- Rodés-Cabau J, "Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches", J Am Coll Cardiol, 57, pp.18~28 (2011)
- Kahlert P, "Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study", Circulation, 121, pp.870~878 (2010)
- Détaint D, "Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence", JACC Cardiovasc Interv, 2, pp.821~827 (2009)
- Kahlert P, "A modified “preclosure” technique after percutaneous aortic valve replacement", Catheter Cardiovasc Interv, 72, pp.877~884 (2008)
- Guetta V, "Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System", Am J Cardiol, 108, pp.1600~1605 (2011)
- Khawaja MZ, "Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative)", Circulation, 123, pp.951~960 (2011)